Your chance to learn from an SMA expert

The latest news on treatments for spinal muscular atrophy has led to more questions than answers. Will everyone get gene therapy? Will an oral treatment become the standard? Is Biogen’s first-mover drug doomed?

That’s why we’re bringing in an expert. The latest edition of our premium conference call service, STAT Expert Advantage, will feature Dr. Edward Smith, a neuromuscular physician from Duke who treats patients with SMA. We’ll be asking him about all the data featured at this month’s American Academy of Neurology conference and drawing on his experience to explain how the future of SMA treatment might shake out.

The call is slated for May 22 at 10 a.m. ET, and if you’d like to tune in and submit questions of your own, you can do so here.